Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
2018 · JAMA Oncology · 2,473 citations
https://doi.org/10.1001/jamaoncol.2018.3923
D
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
215
Papers
9.9K
Citations
30
h-index
48
i10-index
Daniel Wang is an academic researcher from Harold C. Simmons Comprehensive Cancer Center. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Occupational and environmental lung diseases & Pleural and Pulmonary Diseases. The author has an h-index of 30, co-authored 183 publications.
ORCID: 0000-0002-3341-8652Papers by this author
worksAnti–PD-1–Induced Pneumonitis Is Associated with Persistent Imaging Abnormalities in Melanoma Patients
2019 · Cancer Immunology Research · 23 citations
https://doi.org/10.1158/2326-6066.cir-18-0717
Co-expression of estrogen receptor-alpha and targets of estrogen receptor action in proliferating monkey mammary epithelial cells
2006 · Breast Cancer Research · 12 citations
https://doi.org/10.1186/bcr1374
Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma
2025 · Clinical Cancer Research · 2 citations
https://doi.org/10.1158/1078-0432.ccr-24-4024
PD05-09 PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA AT MINORITY SERVING HOSPITALS ARE LESS LIKELY TO UNDERGO DEFINITIVE TREATMENT
2024 · The Journal of Urology · 0 citations
https://doi.org/10.1097/01.ju.0001008624.07191.ab.09
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat